Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 18, 2022

Primary Completion Date

March 7, 2023

Study Completion Date

March 7, 2023

Conditions

Hyperpigmentation

Interventions

DRUG

DBI-102

Topical application on dorsal hand and upper volar arm

DRUG

Vehicle gel

Inactive comparator

DRUG

Hydroquinone Cream

4% Hydroquinone cream, Acella (approved), twice daily for 12 weeks

Trial Locations (1)

Zepeda Dermatologia, Santa Tecla